466 related articles for article (PubMed ID: 14712413)
1. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
[TBL] [Abstract][Full Text] [Related]
4. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
Lu HT; Zhao JG; Li MH; Li YD
Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of thrombolysis and its clinical application in stroke.
Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P
J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866
[TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
Collen D; Stassen JM; De Cock F
Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
[TBL] [Abstract][Full Text] [Related]
8. A new rat model of thrombotic focal cerebral ischemia.
Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
11. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
12. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
13. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
14. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment.
Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
[TBL] [Abstract][Full Text] [Related]
17. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
18. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009].
Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J
Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634
[TBL] [Abstract][Full Text] [Related]
20. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
